Beyond the diaphragm and the lung: a multisystem approach to understanding congenital diaphragmatic hernia
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · May 2023 · 1 min read
In brief
In brief
This review examines the multisystem impact of congenital diaphragmatic hernia beyond the well-studied lung and diaphragm pathology. While pulmonary hypoplasia and hypertension are hallmarks, 60% of CDH survivors face long-term comorbidities affecting the heart, brain, GI tract, kidneys, and musculoskeletal system—areas requiring further research to improve outcomes.
Written by the GCMD Library team from the article.
Abstract
Congenital diaphragmatic hernia (CDH) is a birth defect characterized by the incomplete closure of the diaphragm and herniation of abdominal organs into the chest during gestation. This invariably leads to an impairment in fetal lung development (pulmonary hypoplasia) that involves the pulmonary vessels (vascular remodeling) leading to postnatal pulmonary hypertension. Moreover, approximately 60% of CDH survivors have long-term comorbidities, including critical cardiac anomalies, neurodevelopmental impairment, gastroesophageal reflux, and musculoskeletal malformations. While the pathophysiology of the diaphragmatic defect and pulmonary hypoplasia have been studied in detail over the decades, less is known about the other organs affected in CDH. In this review, we searched the literature for reports on other organs beyond the lung and diaphragm in human and experimental models of CDH. We found studies reporting gross morphometric changes and alterations to biological pathways in the heart, brain, liver, kidney, gastrointestinal tract, and musculoskeletal system. Given the paucity of literature and the importance that these comorbidities play in the life of patients with CDH, further studies are needed to comprehensively uncover the pathophysiology of the changes observed in these other organs.